Baxter International is one step closer in its bid to acquire Hillrom. On Thursday, Hillrom said its shareholders voted to approve the pending $12.4 billion or $156 per share acquisition.
The deal is expected to close in 2021 or early 2022.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,